BioSpace News Archive

Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage

The CHAMPION trial is assessing the effectiveness and safety of heat-stable carbetocin vs. oxytocin, the current standard of care, for preventing PPH after vaginal birth

February 22, 2018

·

9 min read

Pharm Country

Teleflex Highlights LMA® Gastro™ Airway Study, Which Shows Efficacy for Use in Upper Gastrointestinal Endoscopy

Peer-Reviewed Published Study Shows Advantages of LMA® Gastro™ Airway

February 22, 2018

·

4 min read

FDA

Alfa Scientific Designs, Inc. Announces First US FDA 510(k) Clearachnce for Its Driven Flow™ Tenology Product

The US FDA granted the first 510(k) clearance for ALFA’s iFOB with Driven Flow™ Technology. The Instant-view-plus iFOB 510(k) clearance is indicated for professional, CLIA-waived, and over-the-counter (OTC) users.

February 22, 2018

·

2 min read

Genetown

Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting

Syndax Pharmaceuticals, Inc. today announced eight presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting

February 22, 2018

·

5 min read

Drug Development

Global Health Solutions to Pursue Orphan Indication Following Successful Preclinical Data for Ophthalmologic Drug Candidate

Global Health Solutions, LLC, has announced successful in-vitro and in-vivo data for OV-02, a unique biocidal ointment intended to treat and prevent ocular colonization of viruses, such as those that lead to shingles of the eye and pink eye

February 22, 2018

·

2 min read

Business

Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance

Fourth Quarter 2017 Revenues of $595.1 million, up 15.8% Versus Prior Year Period; up 12.6% on Constant Currency Basis

February 22, 2018

·

38 min read

Business

Partner Therapeutics (PTx) Announces the Appointment of Colleen Mockbee as Chief Development Officer

Former Lilly Executive will oversee Development, Regulatory Affairs and Quality

February 22, 2018

·

3 min read

Drug Development

Key U.S. Dry Eye Patent Issued to RegeneRx

RegeneRx Biopharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued a patent for Thymosin beta 4 for use in the treatment of dry eye syndrome

February 22, 2018

·

4 min read

Drug Development

Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease

Arrowhead Pharmaceuticals, Inc.(NASDAQ: ARWR) today announced that it has received approval to proceed with a first-in-human study of ARO-AAT, which is being developed as treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency

February 22, 2018

·

2 min read

Business

Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results

Company Provides Update on Late-stage Microbiome-focused Product Candidates.

February 22, 2018

·

12 min read